Our mission is to improve patient care
and save lives.

We never settle for status quo.
PAVmed is a commercial-stage, diversified medical technology company with an imperative to innovate.

ABOUT

our impact

Lucid Diagnostics Launches First EsoGuard® Mobile Test Unit

Lucid Diagnostics Launches First EsoGuard^® Mobile Test Unit

First esophageal precancer detection event utilizing an EsoGuard mobile test unit to be hosted today by Florida Digestive Health Specialists in Sarasota, Florida.

our Businesses

Delivering health technology innovations.

Our subsidiaries commercialize technologies that offer significant value to healthcare systems, clinicians, and patients—across all sectors of medical technology—device, diagnostics, and digital health.

Diagnostics

Lucid Diagnostics is a medical diagnostics company offering the first and only diagnostics test to detect esophageal precancer and cancer.

View Business

Digital Health

Veris Health is focused on delivering enhanced personalized cancer care through remote patient monitoring using a digital health platform and connected health devices.

View Business

our approach

Pioneering medical technology with a shared-services business model.

Our shared, enabling functions allow us to achieve economies of scale and rapidly deploy resources as needed across our businesses and products.

LEARN MORE

press releases

Read the latest news from PAVmed.

January 13, 2025

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

View Press Release

investor relations

Innovation within reach.

Investing in PAVmed is investing in innovation that has the potential to impact and even transform healthcare. Stay informed about the latest news and updates from our team.

INVESTORS

CONTACT US

Get in touch.

Interested in collaborating or looking for more information about our innovations, events, products or partnerships? Connect with us.

CONTACT

Our mission is to improve patient careand save lives.